Titlebook: Epitranscriptomics; Stefan Jurga,Jan Barciszewski Book 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Sp

Agitated

书目名称Epitranscriptomics影响因子(影响力)




书目名称Epitranscriptomics影响因子(影响力)学科排名




书目名称Epitranscriptomics网络公开度




书目名称Epitranscriptomics网络公开度学科排名




书目名称Epitranscriptomics被引频次




书目名称Epitranscriptomics被引频次学科排名




书目名称Epitranscriptomics年度引用




书目名称Epitranscriptomics年度引用学科排名




书目名称Epitranscriptomics读者反馈




书目名称Epitranscriptomics读者反馈学科排名

友好关系

诙谐

揭穿真相

Deciphering RNA Methylation in Cancer,vance of these approaches for cancer biology research. We also discuss the potential of third-generation sequencing methods for direct detection of RNA methylation and prospects of RNA methylation for anticancer therapy.

联想

Roles of m6A RNA Modification in Normal Development and Disease,f a particular gene m.A thus up/downregulates its expression. This mode of gene expression regulation not only is important for normal developmental processes but also plays major roles in disease processes as evidenced by many recently published studies. Abnormal m.A levels and aberrant expression

Prostatism

From m6A to Cap-Adjacent m6Am and their Effects on mRNAs,have been published regarding how cap-adjacent m.Am marks affect their host mRNA. Discrepancies in the data mean that the effects of cap-adjacent m.Am on mRNA stability, decapping, and translation continue to be debated. Finally, while PCIF1 is predominantly nuclear, a subset of results suggests a p

Prostatism

RNA m6A Modification: The Mediator Between Cellular Stresses and Biological Effects,owed RNA modifications responding to other stresses such as starvation, heat shock, and pathogen infection. For instance, heat shock could directly or indirectly affect distribution and abundance of m.A modification, regulated by m.A modifiers, which in turn influenced the expression of specific gen

灯泡

gusher

contradict

ADAR-Mediated RNA Editing and Its Therapeutic Potentials,create a wholesome perspective on the potential of this molecular mechanism as a tool to correct disease-causing G-to-A point mutations. In this context, clinically relevant approaches and their potential future applications, as well as their currently challenging limitations, will be evaluated.